Industry Insights with Yuning Chen on Recombinant Proteins
Yuning Chen discusses The “ProVir™” collection and the role of recombinant virus proteins in the development of infectious disease treatment regimes and vaccines.
Cutting Edge Conversations 2022
The Cutting Edge Conversations series offers a deep dive into specific research areas and focused insights regarding market-relevant processes from respected firms in the industry.
Cutting Edge Conversations: Discovering New Innovations in Oncology
Experts discuss progress in cancer research, including novel treatments, experimental therapies, and drug development.
Cutting Edge Conversations: Addressing Orphan and Rare Diseases
Joseph Zabinski, PhD, MEM, and Jonathan Kish, PhD, MPH, discuss how research groups are working in the realm of orphan and rare diseases.
Cutting Edge Conversations: Innovative Approaches to Chemistry, Manufacturing and Controls
Episode 4 in the Cutting Edge Conversation series featured Dr. Mujeebur Rahuman, Dr. Holger von Moeller, and Dr. Fernando Huerta as they discuss about industry challenges and innovations surrounding Chemical, Manufacturing and Controls in the life sciences industry.
Cutting Edge Conversations: Value, Access and Evidence – Biotech Market Access
Sajjad Raza, Steven Fountain, and Sonya Snedecor present in Episode 2 of Scientist.com's Cutting Edge Conversations series with a presentation on the challenge research manufacturers face when they need to maximize access for patients with payers. The many considerations for a biotechnology company during various phases of drug development and how companies could use efficient sourcing strategies for market access.
